Tailwinds' Take: Looking forward to seeing more data on the BVA-100. The medical community is just waking up to the incredible savings in mortality associated with proper blood volume management.
NEW YORK, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE...
Accurate blood volume monitoring can save lives and reduce medical costs
The BVA 100 is the only approved product on the market
Hospitals are incentivized to adopt the product
The market opportunity is large
Daxor emerges
Similar to how...
NEW YORK, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an innovative medical instrumentation and biotechnology company focused on blood volume measurement today announces the appointment of Guido Manzo as Vice President of Sales.
"Guido joins Daxor with...
NEW YORK, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces that Aspirus Wausau Hospital in Wausau Wisconsin has acquired a BVA-100...
NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces new data from Duke University Medical Center that was presented Saturday,...